RENEE ARREOLA: Open Payments
NPI 1265904767 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 50 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,053
Food & beverage: $1,053
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $356 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $291 |
| ABBVIE INC. | 10 | $144 |
| Axsome Therapeutics, Inc. | 3 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Collegium Pharmaceutical, Inc. | 2 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Lundbeck LLC | 1 | $28 |
Products named: REXULTI, CAPLYTA, VRAYLAR, Auvelity, ABILIFY ASIMTUFII, TRINTELLIX, Jornay PM, FANAPT.
Industry payments across OR — which companies pay providers there.
